Chugai Pharmaceutical
4519.T
#314
Rank
NZ$134.64 B
Marketcap
NZ$81.82
Share price
-2.16%
Change (1 day)
-11.24%
Change (1 year)

Earnings for Chugai Pharmaceutical (4519.T)

Earnings in 2026 (TTM): NZ$7.64 Billion

According to Chugai Pharmaceutical's latest financial reports the company's current earnings are NZ$8.91 Billion. In 2025 the company made an earning of NZ$7.30 Billion, an increase over its 2024 earnings that were of NZ$6.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Chugai Pharmaceutical from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$7.64 B4.66%
2025 NZ$7.30 B12.63%
2024 NZ$6.48 B13.42%
2023 NZ$5.71 B-23.15%
2022 NZ$7.43 B9.05%
2021 NZ$6.81 B32.48%
2020 NZ$5.14 B47.49%
2019 NZ$3.48 B72.71%
2018 NZ$2.02 B27.68%
2017 NZ$1.58 B25.22%
2016 NZ$1.26 B-4.47%
2015 NZ$1.32 B2.23%
2014 NZ$1.29 B-8.93%
2013 NZ$1.42 B-16.76%
2012 NZ$1.70 B29.55%
2011 NZ$1.31 B-6.25%
2010 NZ$1.40 B-18.94%
2009 NZ$1.73 B